TriaGen Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $661K | Buy |
3,560
+441
| +14% | +$81.9K | 0.2% | 98 |
|
|
2025
Q1 | $653K | Hold |
3,119
| – | – | 0.23% | 86 |
|
|
2024
Q4 | $554K | Hold |
3,119
| – | – | 0.19% | 100 |
|
|
2024
Q3 | $616K | Hold |
3,119
| – | – | 0.21% | 95 |
|
|
2024
Q2 | $535K | Hold |
3,119
| – | – | 0.21% | 96 |
|
|
2024
Q1 | $568K | Sell |
3,119
-867
| -22% | -$158K | 0.24% | 88 |
|
|
2023
Q4 | $618K | Hold |
3,986
| – | – | 0.29% | 76 |
|
|
2023
Q3 | $594K | Sell |
3,986
-28
| -0.7% | -$4.17K | 0.3% | 75 |
|
|
2023
Q2 | $541K | Sell |
4,014
-29
| -0.7% | -$3.91K | 0.25% | 95 |
|
|
2023
Q1 | $644K | Buy |
4,043
+77
| +2% | +$12.3K | 0.32% | 78 |
|
|
2022
Q4 | $641K | Sell |
3,966
-15
| -0.4% | -$2.42K | 0.36% | 76 |
|
|
2022
Q3 | $534K | Hold |
3,981
| – | – | 0.29% | 85 |
|
|
2022
Q2 | $610K | Sell |
3,981
-1,850
| -32% | -$283K | 0.43% | 66 |
|
|
2022
Q1 | $945K | Sell |
5,831
-326
| -5% | -$52.8K | 0.49% | 63 |
|
|
2021
Q4 | $834K | Sell |
6,157
-2,191
| -26% | -$297K | 0.41% | 74 |
|
|
2021
Q3 | $900K | Buy |
8,348
+4,382
| +110% | +$472K | 0.49% | 70 |
|
|
2021
Q2 | $461K | Sell |
3,966
-107
| -3% | -$12.4K | 0.24% | 106 |
|
|
2021
Q1 | $441K | Sell |
4,073
-65
| -2% | -$7.04K | 0.25% | 100 |
|
|
2020
Q4 | $443K | Buy |
+4,138
| New | +$443K | 0.26% | 104 |
|